Pavmed Inc (PAVM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pavmed Inc (PAVM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6502
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed’s product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.

Pavmed Inc (PAVM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pavmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pavmed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pavmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pavmed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pavmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pavmed Inc, Medical Equipment, Deal Details 10
Equity Offering 10
PAVmed Raises USD10.35 Million in Rights Offering of Units 10
PAVmed Raises Funds through Private Placement of Shares up on Exercise of Warrants 12
PAVmed Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD4.8 Million 13
PAVmed Plans to Raise Funds in Secondary Offering of Shares 14
PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 15
PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 16
PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 17
PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 18
PAVmed Raises USD5.3 Million in IPO 19
Debt Offering 21
PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 21
Pavmed Inc – Key Competitors 22
Pavmed Inc – Key Employees 23
Pavmed Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Aug 14, 2018: Pavmed announces second quarter 2018 financial results 25
May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 27
Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 29
Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 31
May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 33
Corporate Communications 34
Jul 11, 2018: PAVmed Appoints Shaun O’Neil Chief Commercial Officer 34
Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 35
Legal and Regulatory 36
Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements 36
Other Significant Developments 37
Aug 14, 2018: Pavmed announces second quarter 2018 financial results 37
Jul 25, 2018: Pavmed provides business update 39
Jun 27, 2018: PAVmed Provides Business Update 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Pavmed Inc, Medical Equipment, Key Facts, 2017 2
Pavmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pavmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pavmed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pavmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pavmed Inc, Deals By Market, 2012 to YTD 2018 8
Pavmed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PAVmed Raises USD10.35 Million in Rights Offering of Units 10
PAVmed Raises Funds through Private Placement of Shares up on Exercise of Warrants 12
PAVmed Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD4.8 Million 13
PAVmed Plans to Raise Funds in Secondary Offering of Shares 14
PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 15
PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 16
PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 17
PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 18
PAVmed Raises USD5.3 Million in IPO 19
PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 21
Pavmed Inc, Key Competitors 22
Pavmed Inc, Key Employees 23

List of Figures
Pavmed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pavmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pavmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pavmed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pavmed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pavmed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pavmed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pavmed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pavmed Inc (PAVM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wintrust Financial Corporation:企業のM&A・事業提携・投資動向
    Wintrust Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wintrust Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析
    Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Apyx Medical Corp (BVX):企業の財務・戦略的SWOT分析
    Summary Apyx Medical Corp (Apyx Medical) formerly known as Bovie Medical Corp is a medical technology company. The company manufactures and develops cosmetic and surgical products. The company also develops J-Plasma, a helium-based plasma surgical product for cutting, coagulation and ablation of sof …
  • ARK Diagnostics Inc:企業の製品パイプライン分析
    Summary ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lam …
  • Cryostar SAS:企業の戦略的SWOT分析
    Cryostar SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • GenMark Diagnostics Inc (GNMK):企業の製品パイプライン分析2018
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Intercontinental Hotels Group Plc
    Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • Abzena Plc (ABZA)-製薬・医療分野:企業M&A・提携分析
    Summary Abzena Plc (Abzena), formerly Polytherics Group Ltd is a life science company that provides complementary services and technologies to enable the selection, development and manufacture of biopharmaceuticals products based on antibodies and other proteins. The company's technologies include a …
  • Ultra Petroleum Corp (UPLC):企業の財務・戦略的SWOT分析
    Ultra Petroleum Corp (UPLC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • ASIT Biotech SA (ASIT):製薬・医療:M&Aディール及び事業提携情報
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • Smiths Group plc:企業の戦略・SWOT・財務分析
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Angelini Group:企業の戦略的SWOT分析
    Angelini Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Breg Inc-医療機器分野:企業M&A・提携分析
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes cold therapy products. The company offers products, which include cold therapy products, hip braces, elbow or wrist braces, knee braces, shoulder braces, spine braces, ankle braces, home therapy kits, and others. I …
  • Namibia Breweries Limited:戦略・SWOT・企業財務分析
    Namibia Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary Namibia Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆